evenfolioETF Details
State Street Investment Management·Health·XBI · NYSE Arca
State Street SPDR S&P Biotech ETF (XBI)
- Price
- $155.98
- —30 Oct 2026
- Assets
- $10.4B
- Total net assets
- Expense ratio
- 0.35%
- Category 1.00%
- Yield
- 0.35%
- Trailing distributions
- 1Y return
- 40.0%+11.2%
- Category 28.8%
- 3Y CAGR
- 34.0%+12.5%
- Category 21.5%
- 5Y CAGR
- 4.7%+0.6%
- Category 4.1%
Loading NAV history…
State Street SPDR S&P Biotech ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -1.1% | +6.1% | +19.7% | +28.1% | +40.0% | +34.0% | +4.7% | +10.8% | +11.8% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -4.7% | -3.8% | -3.3% | +7.6% | +11.2% | +12.5% | +0.6% | 0.0% | +0.1% |
Holdings
The 10 largest positions make up 16.7% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| TWST | Twist Bioscience Corp | 2.21% |
| MRNA | Moderna Inc | 2.04% |
| NTRA | Natera Inc | 1.80% |
| IOVA | Iovance Biotherapeutics Inc | 1.62% |
| AMGN | Amgen Inc | 1.55% |
| BIIB | Biogen Inc | 1.54% |
| UTHR | United Therapeutics Corp | 1.54% |
| ABBV | AbbVie Inc | 1.50% |
| HALO | Halozyme Therapeutics Inc | 1.48% |
| SYRE | Spyre Therapeutics Inc | 1.47% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 4.9
- P/S
- 8.1
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care99.3%
- Financial services0.7%
Asset mix
- Stocks100.0%
- Cash0.0%
ETF details
- Issuer
- State Street Investment Management
- Category
- Equity · Health
- Ticker
- XBI
- Exchange
- NYSE Arca
- Inception
- 31 Jan 2006 (20.7 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.35% (category 1.00%)
- Holdings turnover
- 71% (category 51%)
- Distribution yield
- 0.35%
- Beta, 3 years
- 1.09
- Total net assets
- $10.4B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- IXJ · iShares Global Healthcare ETFiShares · $4.3B · ER 0.38%5Y 6.7%
- IYH · iShares U.S. Healthcare ETFiShares · $4B · ER 0.37%5Y 7.4%
- FHLC · Fidelity MSCI Health Care Index ETFFidelity Investments · $3.5B · ER 0.08%5Y 7.2%
- IHI · iShares U.S. Medical Devices ETFiShares · $3.4B · ER 0.37%5Y -3.1%
- FBT · First Trust NYSE Arca Biotechnology Index FundFirst Trust · $3B · ER 0.55%5Y 11.4%
- ARKG · ARK Genomic Revolution ETFARK ETF Trust · $2.2B · ER 0.75%5Y -7.2%